ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,572.85
0.10%
US Tech 100
19,893.60
0.00%
Dow Jones
39,344.79
-0.08%
Brent Oil
85.25
-0.19%
Bitcoin
57,253.35
0.97%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Vivoryon Therapeut (VVY) Quote

Vivoryon Therapeut

Vivoryon Therapeut (VVY)

EU
1.904
0.00
( 0.00% )
Updated: 03:05:23
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
1.904
Bid
1.892
Ask
1.926
Volume
10,060
1.894 Day's Range 1.93
0.41 52 Week Range 14.10
Market Cap
-
Previous Close
1.904
Open
1.93
Last Trade
5067
@
1.904
Last Trade Time
03:01:18
Financial Volume
-
VWAP
-
Average Volume (3m)
1,265,090
Shares Outstanding
0.00
Dividend Yield
-
PE Ratio
-
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-

About Vivoryon Therapeut

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.vivoryon.com
Headquarters
Halle, Deu
Founded
1970
Vivoryon Therapeut is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker VVY. The last closing price for Vivoryon Therapeut was 1.90 €. Over the last year, Vivoryon Therapeut shares have traded in a share price range of 0.41 € to 14.10 €.

Vivoryon Therapeut currently has 0 shares outstanding.

VVY Latest News

More News

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on...

2 hours ago
UK Regulatory

Vivoryon Therapeutics N.V. Reports Outcome of 2024 Annual General Meeting

Vivoryon Therapeutics N.V. Reports Outcome of 2024 Annual General Meeting Vivoryon Therapeutics N.V. Reports Outcome of 2024 Annual General Meeting Halle (Saale) / Munich, Germany, June 21...

June 21 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results and New Data Reinforcing Strategic Focus in Kidney Disease

Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results and New Data Reinforcing Strategic Focus in Kidney Disease Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results and New...

May 23 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress on May 23, 2024

Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress on May 23, 2024 Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress...

May 15 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. to Hold its 2024 Annual General Meeting on June 21, 2024

Vivoryon Therapeutics N.V. to Hold its 2024 Annual General Meeting on June 21, 2024 Vivoryon Therapeutics N.V. to Hold its 2024 Annual General Meeting on June 21, 2024 Halle (Saale) / Munich...

May 08 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates

Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and...

April 24 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and Operational Progress on April 24, 2024

Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and Operational Progress on April 24, 2024 Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and...

April 16 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Announces Changes to Board Composition

Vivoryon Therapeutics N.V. Announces Changes to Board Composition Vivoryon Therapeutics N.V. Announces Changes to Board Composition Halle (Saale) / Munich, Germany, March 15, 2024 – Vivoryon...

March 15 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.016-0.8333333333331.921.981.851298641.93636037DE
4-0.611-24.29423459242.5152.6151.3245978551.97620284DE
121.4045281.1811811810.49956.30.4112650902.14059983DE
26-6.226-76.58056580578.139.930.418809191.90718455DE
52-9.936-83.918918918911.8414.10.414716002.40503223DE
156-19.146-90.954869358721.0522.580.411998114.55977288DE
260-3.696-665.623.250.411562875.58700876DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.175
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.2401
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.37
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.425
(0.00%)
0
AACGATA Creativity Global
$ 0.825
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.175
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.2401
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.37
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.425
(0.00%)
0
AACGATA Creativity Global
$ 0.825
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.175
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.2401
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.37
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.425
(0.00%)
0
AACGATA Creativity Global
$ 0.825
(0.00%)
0

Discussion

View Full Feed
Nukemtiltheyglow Nukemtiltheyglow 6 minutes ago
You mean Kiwi was wrong about Epadel waiting in the wings? Say it isn’t so….
It took Amarin and Eddingpharm years it seems to get China to approve Vazkepa.

Now all of a sudden “Mr Facto” blundered? The master of the innuendo.

Do the Chinese like the Japs? I mea
AMRN
littlejohn littlejohn 11 minutes ago
A much bigger threat from Beryl was

dodged...

Beryl injested dry air for almost

two days before landfall...

Beryl intensity increase from tropical

storm to hurricane only had about

six to eight hours to get the
knrorrel knrorrel 11 minutes ago
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174722632
RSPI
Seminole Red Seminole Red 11 minutes ago
with a 4 billion injection from VW, Rivian may be one of the few electric vehicles to be successful but its going to take a few years.....
RIVN
Jackxkr Jackxkr 11 minutes ago
You are the most worrhless little man here. Just am annoying little flea of a man. You like to here your own voice going cheep, cheep, cheep look at me. Tiny man syndrome written all over your post's.
NWBO
RichieBoy RichieBoy 11 minutes ago
IHUB privacy can be more like Public Commons.

Well at times anyway, sounds like you're probably signed out. I think if you sign back into IHUB things might look differently and more desireable.
AFFU
reindlll reindlll 13 minutes ago
More oure wish then knowledge
IGEN
EHRjunkie EHRjunkie 13 minutes ago
In yesterdays' tweet: IRB established.

The Institutional Review Board reviews and monitors biomedical research involving human subjects (Halberd is conducting clinical trials on Veterans and active duty personel). In accordance with FDA regulations, an IRB has the authority to approve
HALB
satter satter 14 minutes ago
The 2 Morons here with multiple user names keep posting about Project 2025, which is from The Heritage Foundation, which has NOTHING to do with MAGA


Heritage Foundation has NOTHING to do with MAGA/TRUMP?

Can those Maga lips lie any better than that?
DJT
knrorrel knrorrel 15 minutes ago
$30 wow crazy - back to $5 would be nice now

imho
MAXN
knrorrel knrorrel 16 minutes ago
why only Friday, could MAXN reach $1 as early as Thursday - is Friday an important day? ....... I think sooner or later MAXN could go back well above the dollar in 2024
imho

MAXN
Menace212 Menace212 18 minutes ago
All shareholders should take a look at this message I just sent
RSPI
RichieBoy RichieBoy 19 minutes ago
Mind linking that video please DJ?
Quite fascinating 🤨
AFFU
Menace212 Menace212 19 minutes ago
“Arnold S. Lippa, the Company’s Interim President and Interim Chief Executive Officer and the Company’s Chief Scientific Officer, and a director who was awarded 70,000,000 shares of Phantom Stock and Jeff Eliot Margolis, the Company’s Senior Vice President, Chief Financial Officer, Treasurer and Sec
RSPI
littlejohn littlejohn 22 minutes ago
Taiwan only has China and earthquakes to

watch out for everyday...

https://apnews.com/article/china-taiwan-safety-warning-af2bb9e74087acfef1f6c8677326d6d6

https://www.cwa.gov.tw/V8/E/E/index.html

The increase and ongoing seismic activity
declaes declaes 22 minutes ago
From the company:

More rev and income from the new beds at the beginning of July 2024!!!

ARIA will license the Building to operate 12 detox beds and 13 residential beds.   The new beds will be higher level care beds which will result in a roughly 50% increase in revenue
GRST
knrorrel knrorrel 24 minutes ago
WOW HEY , ALL READ THIS GREAT POST, 100% AGREEMENT


Good questions, none of which the 8k answers, so I’m not liking the response you got to be honest. The 8k was vague and if he chose to mention the EM and filings issue in the 8k, then he should have elaborated further. Becaus
RSPI
Wise Man Wise Man 25 minutes ago
MORE POTTING AND LESS PLOTTING.
https://x.com/CarlosVignote/status/1810239009139859803?t=sKvxCjI8L04rwQldSgBivg&s=19
FNMA
knrorrel knrorrel 26 minutes ago
WOW HEY , ALL READ THIS GREAT POST, 100% AGREEMENT


Good questions, none of which the 8k answers, so I’m not liking the response you got to be honest. The 8k was vague and if he chose to mention the EM and filings issue in the 8k, then he should have elaborated further. Becaus
RSPI
Seminole Red Seminole Red 31 minutes ago
showing 6 am for me this am at DK
snow snow 34 minutes ago
Boiler Some sorts of reporting can be formally correct and at the same time very misleading. That is the case here. You yourself mislead investors by ignoring the net interest shareholders have in the revenues reported despite the fact that it is substantially lower than the numbers reported.
IQST
Ray_137 Ray_137 36 minutes ago
I will sell 10 k CTs for $5. If there is a buyer.
LEHNQ
B_B! B_B! 36 minutes ago
Mirror, Mirror on the Wall, Who's the Greenest of Them All?
Is Plug Power the Nikola customer in New York?


“We’re seeing green shoots with repeat and new fleets — some in new markets such as New York,” he said on the call. “While our initial focus has been California an
PLUG

Your Recent History

EU
VVY
Vivoryon Therapeut
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved